Qiming U.S. Healthcare GP II Form 3 Jasper Therapeutics / MARK MCDADE ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Qiming U.S. Healthcare Fund II, L.P.

(Last) (First) (Middle)

11100 NE 8TH ST, SUITE 200

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2021

3. Issuer Name and Ticker or Trading Symbol
Jasper Therapeutics, Inc. [ JSPR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Voting Common Stock	5,852,982	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Qiming U.S. Healthcare Fund II, L.P.

(Last) (First) (Middle)

11100 NE 8TH ST, SUITE 200

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Qiming U.S. Healthcare GP II, LLC

(Last) (First) (Middle)

11100 NE 8TH ST, SUITE 200

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

MCDADE MARK

(Last) (First) (Middle)

11100 NE 8TH ST, SUITE 200

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

Explanation of Responses:

1. The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP. Each of Qiming GP, Mr. Rieschel and Mr. McDade may be deemed to beneficially own the shares owned by Qiming.

	By: /s/ Mark D. McDade, Managing Partner of Qiming U.S. Healthcare GP II, LLC, General Partner of Qiming U.S. Healthcare Fund II, L.P.	10/01/2021
	By: /s/ Mark McDade, Managing Partner of Qiming U.S. Healthcare GP II, LLC	10/01/2021
	By: /s/ Mark McDade	10/01/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.